Severe Dupilumab-Associated Ocular Surface Disease: Multicenter Experience and Management Considerations.
Severe DAOSD may be underrecognized, as mild early symptoms can delay referral and allow progression to advanced, vision-threatening complications and early ophthalmologic evaluation and timely referral are essential to prevent irreversible ocular surface damage and vision loss.